Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: A coincidence or more?

British Journal of Dermatology

Volumn 149, Issue 4, 2003, Pages 869-876

  Kazakov, D V ^a   Mentzel, T ^b   Burg, G ^a   Dummer, R ^a   Kempf, W ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Dermatopathologische Gemeinschaftspraxis   (Germany)

Author keywords

Agranular CD4+ CD56+ haematodermic neoplasm; Blastic natural killer cell lymphoma leukaemia; DC2 plasmacytoid cells; Myelodysplastic syndrome; Plasmacytoid monocytes

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CELL MARKER; CORTICOSTEROID; CYTOTOXIC FACTOR; DNA NUCLEOTIDYLEXOTRANSFERASE; GEMCITABINE; T LYMPHOCYTE RECEPTOR; THALIDOMIDE;

AGED; ARTICLE; BLASTIC NATURAL KILLER CELL LYMPHOMA; CASE REPORT; CLINICAL FEATURE; CYTOPENIA; DEATH; DETERIORATION; DISEASE ASSOCIATION; DYSPLASIA; EXTRAVASATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOMA; MALE; MONOCYTE; MOUTH MUCOSA; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; PLASMA CELL; PRIORITY JOURNAL; REFRACTORY ANEMIA; SIDEROBLASTIC ANEMIA; SKIN DEFECT; SKIN INFILTRATE;

AGED; AGED, 80 AND OVER; FATAL OUTCOME; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, MYELOMONOCYTIC, ACUTE; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MYELODYSPLASTIC SYNDROMES; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; SKIN NEOPLASMS;

EID: 0242719903     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05639.x     Document Type: Article

References (22)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW. eds. World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue. Lyon: IARC Press. 2001; 351.
2. Petrella T, Comeau MR, Maynadie M et al. 'Agranular CD4+ CDS 6+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002; 26: 852-62.
3. Chaperot L, Bendriss N, Manches O et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001; 97: 3210-17.
4. Knudsen H, Grønbæk K, thor Straten P et al. A case of lymphoblastoid natural killer (NK)-cell lymphoma: association with the NK-cell receptor complex CD94/NKG2 and TP53 intragenic deletion. Br J Dermatol 2002; 146: 148-53.
5. Nagatani T, Okazawa H, Kambara T et al. Cutaneous monomorphous CD4-and CD56-positive large-cell lymphoma. Dermatology 2000; 200: 202-8.
6. Kojima H, Bai A, Mukai HY et al. Chronic myelomonocytic leukemia derived from a possible common progenitor of monocytes and natural killer cells. Leuk Lymphoma 2000; 37: 617-21.
7. Khoury JD, Medeiros LJ, Manning JT et al. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer 2002; 94: 2401-8.
8. Strupp C, Aivado M, Germing U et al. Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: two case reports. Leuk Lymphoma 2002; 43: 133-7.
9. Feuillard J, Jacob MC, Valensi F et al. Clinical and biologic features of CD4(+) CD56(+) malignancies. Blood 2002; 99: 1556-63.
10. Facchetti F, De Wolf-Peeters C, van den Oord JJ et al. Plasmacytoid monocytes (so-called plasmacytoid T cells) in Hodgkin's disease. J Pathol 1989; 158: 57-65.
11. Baddoura FK, Hanson C, Chan WC. Plasmacytoid monocyte proliferation associated with myeloproliferative disorders. Cancer 1992; 69: 1457-67.
12. Facchetti F, De Wolf-Peeters C, Kennes C et al. Leukemia-associated lymph node infiltrates of plasmacytoid monocytes (so-called plasmacytoid T-cells). Evidence for two distinct histological and immunophenotypical patterns. Am J Surg Pathol 1990; 14: 101-12.
13. Horny HP, Kaiserling E, Handgretinger R et al. Evidence for a lymphotropic nature of circulating plasmacytoid monocytes: findings from a case of CD56+ chronic myelomonocytic leukemia. Eur J Haematol 1995; 54: 209-16.
14. Suzuki R, Nakamura S. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia. Leuk Res 1999; 23: 615-24.
15. Handa H, Motohashi S, Isozumi K et al. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside. Acta Haematol 2002; 108: 47-52.
16. Ikewaki J, Otsuka E, Satou J et al. Myeloid/natural killer cell precursor acute leukaemia with minor bcr/abl mRNA transcript. Br J Haematol 2002; 118: 684-5.
17. Inaba T, Shimazaki C, Sumikuma T et al. Clinicopathological features of myeloid/natural killer (NK) cell precursor acute leukemia. Leuk Res 2001; 25: 109-13.
18. Scott AA, Head DR, Kopecky KJ et al. HLA-DR-, CD33+, CD56+, CD16-myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood 1994; 84: 244-55.
19. Meech SJ, McGavran L, Odom LF et al. Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4-anaplastic lymphoma kinase gene fusion. Blood 2001; 98: 1209-16.
20. Kahl C, Pelz AF, Bartsch R et al. Myeloid/natural killer cell precursor blast crisis of chronic myelogenous leukemia with two Philadelphia (Ph-1) chromosomes. Ann Hematol 2001; 80: 58-61.
21. Ino T, Tsuzuki M, Okamoto M et al. Acute leukemia with the phenotype of a natural killer/T cell bipotential precursor. Ann Hematol 1999; 78: 43-7.
22. Miller JS, McCullar V, Punzel M et al. Single adult human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. Blood 1999; 93: 96-106.